State of art in the chemistry of nucleoside-based Pt(II) complexes

Bioorg Chem. 2023 Feb:131:106325. doi: 10.1016/j.bioorg.2022.106325. Epub 2022 Dec 16.

Abstract

After the fortuitous discovery of the anticancer properties of cisplatin, many Pt(II) complexes have been synthesized, to obtain less toxic leads which could overcome the resistance phenomena. Given the importance of nucleosides and nucleotides as antimetabolites, studying their coordinating properties towards Pt(II) ions is challenging for bioorganic and medicinal chemistry. This review aims to describe the results achieved so far in the aforementioned field, paying particular attention to the synthetic aspects, the chemical-physical characterization, and the biological activities of the nucleoside-based Pt(II) complexes.

Keywords: Anticancer drugs; Cancer; Chemotherapy; Cisplatin; DNA; G-Quadruplex; Nucleosides; Pt(II) complexes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Cisplatin / chemistry
  • Coordination Complexes* / pharmacology
  • Nucleosides / pharmacology
  • Nucleotides
  • Platinum Compounds* / chemistry
  • Platinum Compounds* / pharmacology

Substances

  • Antineoplastic Agents
  • Cisplatin
  • Coordination Complexes
  • Nucleosides
  • Nucleotides
  • Platinum Compounds